PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Methotrexate (Rheumatism)
Presentation Product Chemical substance Chapter Items dispensed
Methotrexate 12.5mg/5ml oral liquid
1001030U0AAAKAK
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 2
Methotrexate 20mg/2ml inj pre-filled syringes
1001030U0AABABA
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 2
Methotrexate 10mg/1ml inj pre-filled syringes
1001030U0AABBBB
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 12mg/5ml oral liquid
1001030U0AAASAS
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 15mg/1.5ml inj pre-filled syringes
1001030U0AABCBC
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 15mg/5ml oral liquid
1001030U0AAARAR
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 17.5mg/5ml oral liquid
1001030U0AAATAT
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 18mg/5ml oral liquid
1001030U0AAAXAX
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 1mg/5ml oral liquid
1001030U0AAALAL
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 20mg/1ml inj pre-filled syringes
1001030U0AABSBS
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 20mg/5ml oral liquid
1001030U0AAAVAV
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 22.5mg/5ml oral liquid
1001030U0AAAYAY
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 25mg/1.25ml inj pre-filled syringes
1001030U0AABPBP
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 25mg/2.5ml inj pre-filled syringes
1001030U0AABDBD
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 25mg/5ml oral liquid
1001030U0AAAAAA
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 27.5mg/0.55ml inj pre-filled syringes
1001030U0AABNBN
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 3.75mg/5ml oral liquid
1001030U0AAAJAJ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 30mg/1.5ml inj pre-filled syringes
1001030U0AABRBR
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 4mg/5ml oral liquid
1001030U0AAAUAU
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 50mg/5ml oral liquid
1001030U0AAANAN
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 5mg/5ml oral liquid
1001030U0AAAFAF
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 6mg/5ml oral liquid
1001030U0AAAWAW
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 7.5mg/0.75ml inj pre-filled syringes
1001030U0AAAZAZ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 750micrograms/5ml oral liquid
1001030U0AAAQAQ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 7mg/5ml oral liquid
1001030U0AAAMAM
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.